160 related articles for article (PubMed ID: 12893195)
1. Reduced Fhit expression in cervical carcinoma: correlation with tumor progression and poor prognosis.
Huang LW; Chao SL; Chen TJ
Gynecol Oncol; 2003 Aug; 90(2):331-7. PubMed ID: 12893195
[TBL] [Abstract][Full Text] [Related]
2. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between the reduction of FHIT expression and the development of cervical carcinoma].
Liu H; Peng ZL; Yang KX; Liu SL; Wang H; Zhang CS; Fan YJ; Zheng A
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):846-8. PubMed ID: 15573771
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms.
Huang LW; Chao SL; Hwang JL; Chou YY
Gynecol Oncol; 2002 Jun; 85(3):524-8. PubMed ID: 12051885
[TBL] [Abstract][Full Text] [Related]
5. FHIT alterations in cancerous and non-cancerous cervical epithelium.
Yoshino K; Enomoto T; Nakamura T; Sun H; Ozaki K; Nakashima R; Wada H; Saitoh J; Watanabe Y; Noda K; Murata Y
Int J Cancer; 2000 Jan; 85(1):6-13. PubMed ID: 10585575
[TBL] [Abstract][Full Text] [Related]
6. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
7. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
Yoon SO
Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
[TBL] [Abstract][Full Text] [Related]
8. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
[No Abstract] [Full Text] [Related]
9. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
Butler D; Collins C; Mabruk M; Barry Walsh C; Leader MB; Kay EW
J Pathol; 2000 Dec; 192(4):502-10. PubMed ID: 11113868
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between folate deficiency and aberrant expression related to fragile histidine triad gene in the progression of cervical cancerization].
Chen X; Wang J; Bai L; Ding L; Wu T; Bai L; Xu J; Sun X
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Apr; 36(4):387-92. PubMed ID: 25975556
[TBL] [Abstract][Full Text] [Related]
11. No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Int J Gynecol Cancer; 2003; 13(2):192-6. PubMed ID: 12657123
[TBL] [Abstract][Full Text] [Related]
12. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer.
Butler D; Collins C; Mabruk M; Leader MB; Kay EW
Gynecol Oncol; 2002 Aug; 86(2):144-9. PubMed ID: 12144820
[TBL] [Abstract][Full Text] [Related]
13. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
14. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
15. [Study on the relationship between LOH and MI of FHIT gene and the development of cervical carcinoma].
Liu H; Peng ZL; Wang H; Liu SL; Zhang CS; Tang QP; He B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):506-9. PubMed ID: 16078573
[TBL] [Abstract][Full Text] [Related]
16. FHIT (fragile histidine triad) gene analysis in cervical intraepithelial neoplasia.
Liu FS; Hsieh YT; Chen JT; Ho ES; Hung MJ; Lin AJ
Gynecol Oncol; 2001 Aug; 82(2):283-90. PubMed ID: 11531281
[TBL] [Abstract][Full Text] [Related]
17. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of fragile histidine triad expression in prostate carcinoma.
Fouts RL; Sandusky GE; Zhang S; Eckert GJ; Koch MO; Ulbright TM; Eble JN; Cheng L
Cancer; 2003 Mar; 97(6):1447-52. PubMed ID: 12627509
[TBL] [Abstract][Full Text] [Related]
19. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells.
Wu R; Connolly DC; Dunn RL; Cho KR
J Natl Cancer Inst; 2000 Feb; 92(4):338-44. PubMed ID: 10675384
[TBL] [Abstract][Full Text] [Related]
20. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
